Takeda R&D chief discloses ADS and RSU holdings

TAKEDA PHARMACEUTICAL CO LTD director and President of R&D Andrew Stewart Plump filed an initial Form 3 reporting his holdings in American Depositary Shares.

Accepted by SEC EDGAR 03/18/2026 - 06:08 AM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

TAKEDA PHARMACEUTICAL CO LTD director and President of R&D Andrew Stewart Plump filed an initial Form 3 reporting his holdings in American Depositary Shares. He reports 594,102 ADS held directly and 281,307 ADS held indirectly through a trust. A footnote states that these figures include 251,962 restricted stock units that convert into ADS as they vest on July 1, 2026, July 1, 2027, and July 1, 2028.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Plump Andrew Stewart

Role President, R&D

Type	Security	Shares	Price	Value
Holding	American Depositary Shares	--	--	--
Holding	American Depositary Shares	--	--	--

Holdings: American Depositary Shares — 594,102 shares (Direct); American Depositary Shares — 281,307 shares (Indirect, By Trust)

Footnotes (1)

F1. Includes 251,962 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (117,008 shares), July 1, 2027 (91,580 shares) and July 1, 2028 (43,374 shares).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Andrew Stewart Plump report in his Form 3 for TAK?

He reports his initial ownership in Takeda ADS. This includes 594,102 American Depositary Shares held directly and 281,307 ADS held indirectly through a trust, establishing his total reported equity stake as a company insider.

How many Takeda (TAK) shares does Andrew Stewart Plump hold directly?

He reports direct ownership of 594,102 American Depositary Shares. This figure reflects shares registered in his own name and forms the core of his disclosed personal stake in Takeda Pharmaceutical Co Ltd.

What indirect Takeda (TAK) holdings does Andrew Stewart Plump disclose?

He discloses 281,307 American Depositary Shares held indirectly through a trust. This indicates additional economic exposure to Takeda beyond his directly registered shares, attributed to a trust relationship.

How many Takeda (TAK) RSUs does Andrew Stewart Plump have?

He has 251,962 restricted stock units included in the totals. Each RSU represents a contingent right to receive one American Depositary Share, providing additional potential future equity if vesting conditions are satisfied.

When do Andrew Stewart Plump’s Takeda (TAK) RSUs vest?

The RSUs vest in three tranches: 117,008 on July 1, 2026, 91,580 on July 1, 2027, and 43,374 on July 1, 2028. Each vested RSU converts into one American Depositary Share.

Does this Takeda (TAK) Form 3 show any insider buying or selling?

No new buying or selling is reported; the filing is an initial statement of holdings. It summarizes Andrew Stewart Plump’s direct and indirect ADS ownership and RSU awards rather than recording market transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Plump Andrew Stewart

(Last)

(First)

(Middle)

300 MASSACHUSETTS AVE.

(Street)

CAMBRIDGE

MASSACHUSETTS

02139

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, R&D

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares	594,102⁽¹⁾	D
American Depositary Shares	281,307	I	By Trust

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Includes 251,962 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (117,008 shares), July 1, 2027 (91,580 shares) and July 1, 2028 (43,374 shares).

Remarks:

Exhibit 24 Power of Attorney

	/s/ Max Heuer, by power of attorney, for Andrew Plump	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR